A detailed history of Man Group PLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Man Group PLC holds 14,175 shares of ANIP stock, worth $756,236. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,175
Previous 6,320 124.29%
Holding current value
$756,236
Previous $402,000 110.2%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$54.33 - $65.72 $426,762 - $516,230
7,855 Added 124.29%
14,175 $845,000
Q2 2024

Aug 14, 2024

SELL
$58.53 - $68.82 $63,622 - $74,807
-1,087 Reduced 14.68%
6,320 $402,000
Q1 2024

May 15, 2024

BUY
$54.2 - $69.69 $125,473 - $161,332
2,315 Added 45.46%
7,407 $512,000
Q4 2023

Feb 14, 2024

BUY
$48.72 - $65.43 $248,082 - $333,169
5,092 New
5,092 $280,000
Q1 2021

May 17, 2021

SELL
$28.4 - $36.14 $2.02 Million - $2.57 Million
-71,090 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$23.69 - $31.47 $274,804 - $365,052
-11,600 Reduced 14.03%
71,090 $2.06 Million
Q3 2020

Nov 16, 2020

BUY
$26.38 - $33.1 $577,352 - $724,426
21,886 Added 35.99%
82,690 $2.33 Million
Q2 2020

Aug 14, 2020

SELL
$29.93 - $50.1 $277,690 - $464,827
-9,278 Reduced 13.24%
60,804 $1.97 Million
Q1 2020

May 15, 2020

SELL
$30.35 - $67.14 $1.31 Million - $2.89 Million
-43,012 Reduced 38.03%
70,082 $2.86 Million
Q4 2019

Feb 18, 2020

BUY
$55.65 - $79.83 $1.56 Million - $2.24 Million
28,100 Added 33.06%
113,094 $6.98 Million
Q3 2019

Nov 14, 2019

BUY
$64.7 - $85.39 $5.5 Million - $7.26 Million
84,994 New
84,994 $6.19 Million
Q4 2018

Feb 14, 2019

SELL
$41.17 - $56.44 $343,275 - $470,596
-8,338 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$52.95 - $71.34 $280,952 - $378,530
5,306 Added 175.0%
8,338 $471,000
Q2 2018

Aug 14, 2018

BUY
$56.38 - $68.08 $170,944 - $206,418
3,032 New
3,032 $203,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $930M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.